Efficacy of bilvadi gutika in allergic conditions

A clinical study to evaluate the efficacy of bilvadi gutika in blood eosinophilia - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088752

Enrollment

Registered

2025-06-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D899- Disorder involving the immune mechanism, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patient suffering from allergic asthma, allergic cough and allergic skin manifestation since 1 year. diagnosed cases of allergy with not more than 1 year. raised total and absolute eosinophil counts. patient with who have taken anthelminthic drugs at least 3-4 months before.

Exclusion criteria

Exclusion criteria: patient suffering from psychological disorders, pregnant and lactating women. patient suffering from other systemic diseases or other skin diseases that interfere in prognosis and treatment of disease. patient suffering from fatal diseases like carcinoma of lungs and immunocompromised cases.

Design outcomes

Primary

Measure	Time frame
Reduce in absolute eosinophil countsTimepoint: Reduce in absolute eosinophil counts	—

Secondary

Measure	Time frame
reduction in subjective parameter.Timepoint: reduction in symptoms & signs	—

Countries

India

Contacts

Public ContactDR SUMANTH SHENOY H

Alvas ayurveda medical hospital

shenoysumanth@gmail.com7353162353

Outcome results